Abiopharma

News list

📋 CHRISTOPHER CLINE (Officer) plans to sell 1K shares of TRAVERE THERAPEUTICS, INC. (at $42.61 each, total $43K) Filed: Apr 15, 2026 | ID: 003478

Full text

News bot April 15, 2026, 8:14 p.m.
📋 Form 144 Filing: CHRISTOPHER CLINE

Company: TRAVERE THERAPEUTICS, INC.

Filing Date: 2026-04-15

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 1,014
- Price per Share: $42.61
- Total Value: $43,206.54
- Planned Sale Date: 2026-04-15
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36257
- Issuer Contact Phone: 888-969-7879
- Issuer Address: 3611 Valley Centre Drive, Suite 300, San Diego, CA, 92130
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 92241550.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 5
- Signature: /s/ Christopher Cline